Rodrigo Cristofoletti

1.6k total citations
88 papers, 1.1k citations indexed

About

Rodrigo Cristofoletti is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Analytical Chemistry. According to data from OpenAlex, Rodrigo Cristofoletti has authored 88 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pharmaceutical Science, 22 papers in Pediatrics, Perinatology and Child Health and 19 papers in Analytical Chemistry. Recurrent topics in Rodrigo Cristofoletti's work include Drug Solubulity and Delivery Systems (41 papers), Analytical Methods in Pharmaceuticals (19 papers) and Pharmaceutical studies and practices (18 papers). Rodrigo Cristofoletti is often cited by papers focused on Drug Solubulity and Delivery Systems (41 papers), Analytical Methods in Pharmaceuticals (19 papers) and Pharmaceutical studies and practices (18 papers). Rodrigo Cristofoletti collaborates with scholars based in United States, Germany and Netherlands. Rodrigo Cristofoletti's co-authors include Jennifer Dressman, James E. Polli, Vinod P. Shah, Nikunjkumar Patel, Bertil Abrahamsson, Peter Langguth, D.W. Groot, Nikoletta Fotaki, Stephan Schmidt and Naseem A. Charoo and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Rodrigo Cristofoletti

86 papers receiving 1.1k citations

Peers

Countries citing papers authored by Rodrigo Cristofoletti

Since Specialization

Citations

This map shows the geographic impact of Rodrigo Cristofoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Cristofoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Cristofoletti more than expected).

Fields of papers citing papers by Rodrigo Cristofoletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodrigo Cristofoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Cristofoletti. The network helps show where Rodrigo Cristofoletti may publish in the future.

Co-authorship network of co-authors of Rodrigo Cristofoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Rodrigo Cristofoletti. A scholar is included among the top collaborators of Rodrigo Cristofoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodrigo Cristofoletti. Rodrigo Cristofoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biowaiver monographs for immediate-release solid oral dosage forms: Voriconazole 2024 ·Journal of Pharmaceutical Sciences ·(unknown), Bertil Abrahamsson, Naseem A. Charoo, Rodrigo Cristofoletti, René Holm, Atsushi Kambayashi, Peter Langguth, Alan Parr, James E. Polli, Vinod P. Shah, Jennifer Dressman	4
2	Development of breakthrough bleeding model of combined‐oral contraceptives utilizing model‐based meta‐analysis 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), Serge Guzy, Rodrigo Cristofoletti, (unknown), (unknown), Brian Cicali, Valvanera Vozmediano, Stephan Schmidt	0
3	The Art and Science of Physiologically-Based Pharmacokinetics Modeling 2024 ·Rodrigo Cristofoletti, Amin Rostami‐Hodjegan	2
4	Impact of obesity and roux‐en‐Y gastric bypass on the pharmacokinetics of (R)‐ and (S)‐omeprazole and intragastric pH 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Valvanera Vozmediano, (unknown), Daan J. Touw, (unknown), Rodrigo Cristofoletti, Wilson Salgado, Natália Valadares de Moraes	2
5	Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population‐based analysis 2024 ·British Journal of Clinical Pharmacology ·(unknown), Valvanera Vozmediano, Rodrigo Cristofoletti, Jinmai Jiang, Thomas D. Schmittgen, Cristiane Masetto de Gaitani, Rafael Kemp, Ajith Kumar Sankarankutty, José Sebastião dos Santos, Wilson Salgado, Natália Valadares de Moraes	1
6	Challenges in Permeability Assessment for Oral Drug Product Development 2023 ·Pharmaceutics ·Mirko Koziolek, Patrick Augustijns, (unknown), Rodrigo Cristofoletti, David Dahlgren, Janneke Keemink, Pär Matsson, Fiona McCartney, Marco Metzger, Mario Mezler, (unknown), James E. Polli, Maria Vertzoni, Werner Weitschies, Jennifer Dressman	12
7	Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Stephan Schmidt, Valvanera Vozmediano, Rodrigo Cristofoletti, Sarah Kim, Zhoumeng Lin, Natália Valadares de Moraes, (unknown), Brian Cicali, Hans Leuenberger, Joshua D. Brown, Jin Y. Jin, Cynthia J. Musante, Stacey Tannenbaum, Yaning Wang	4
8	Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Brian Cicali, Viera Lukáčová, Rodrigo Cristofoletti, Stephan Schmidt	6
9	Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions 2023 ·Pharmaceutics ·(unknown), Viera Lukáčová, (unknown), (unknown), (unknown), Mónica Rodríguez, Rodrigo Cristofoletti, (unknown), Elena Suárez, Stephan Schmidt, Valvanera Vozmediano	1
10	Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation 2021 ·Pharmaceutics ·(unknown), (unknown), Tao Long, (unknown), Galina Bernstein, Pierre Martineau, (unknown), Rodrigo Cristofoletti, Stephan Schmidt, Valvanera Vozmediano	4
11	Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help 2021 ·Biopharmaceutics & Drug Disposition ·Fang Wu, Rodrigo Cristofoletti, Liang Zhao, Amin Rostami‐Hodjegan	17
12	Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition 2021 ·The Journal of Clinical Pharmacology ·Tao Long, Rodrigo Cristofoletti, Brian Cicali, Véronique Michaud, Pamela Dow, Jacques Turgeon, Stephan Schmidt	8
13	Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse–Berenice-78 Trypanosoma cruzi Strain Model 2020 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Fernanda de Lima Moreira, (unknown), Rodrigo Cristofoletti, (unknown), (unknown), (unknown), (unknown), Paula Melo de Abreu Vieira, Cláudia Martins Carneiro	6
14	Assessing the impact of cystic fibrosis on the antipyretic response of ibuprofen in children: Physiologically‐based modeling as a candle in the dark 2020 ·British Journal of Clinical Pharmacology ·Brian Cicali, Tao Long, Sarah Kim, Rodrigo Cristofoletti	6
15	Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b) 2020 ·Pharmaceutics ·Bart Hens, Marival Bermejo, Patrick Augustijns, Rodrigo Cristofoletti, Gregory E. Amidon, Gordon L. Amidon, (unknown), (unknown)	7
16	FaSSIF-V3, but not compendial media, appropriately detects differences in the peak and extent of exposure between reference and test formulations of ibuprofen 2016 ·European Journal of Pharmaceutics and Biopharmaceutics ·Rodrigo Cristofoletti, Jennifer Dressman	19
17	A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: A cross-sectional survey with 500 bioequivalence studies 2013 ·Journal of Pharmaceutical Sciences ·Rodrigo Cristofoletti, Chang Chiann, Jennifer Dressman, Sı́lvia Storpirtis	34
18	Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate 2013 ·Journal of Pharmaceutical Sciences ·Naseem A. Charoo, Areeg Anwer Ali, (unknown), Bertil Abrahamsson, Rodrigo Cristofoletti, D.W. Groot, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah, Jennifer Dressman	11
19	Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levofloxacin 2011 ·Journal of Pharmaceutical Sciences ·(unknown), Rodrigo Cristofoletti, (unknown), Sı́lvia Storpirtis, Hans E. Junginger, Sabine Kopp, Kamal K. Midha, Vinod P. Shah, Salomon Stavchansky, Jennifer Dressman, D.M. Barends	48
20	Cyclooxygenase-independent mechanism of ibuprofen-induced antipyresis: the role of central vasopressin V1 receptors 2010 ·Fundamental and Clinical Pharmacology ·Denis de Melo Soares, Rodrigo Cristofoletti, (unknown), C.J. Lindsey, Fabiane H. Veiga‐Souza, Aline S.C. Fabricio, Glória Emília Petto de Souza	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact